We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
189 hedge funds and large institutions have $3.86B invested in Madrigal Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 80 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
402% more capital invested
Capital invested by funds: $769M → $3.86B (+$3.09B)
350% more funds holding in top 10
Funds holding in top 10: 2 → 9 (+7)
248% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 23
40% more funds holding
Funds holding: 135 → 189 (+54)
38% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 39
8.79% more ownership
Funds ownership: 69.17% → 77.96% (+8.8%)
31% less call options, than puts
Call options by funds: $379M | Put options by funds: $546M
Holders
189
Holders Change
+54
Holders Change %
+40%
% of All Funds
3.04%
Holding in Top 10
9
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+350%
% of All Funds
0.14%
New
80
Increased
54
Reduced
39
Closed
23
Calls
$379M
Puts
$546M
Net Calls
-$167M
Net Calls Change
-$155M
Top Buyers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$42.1M |
| 2 |
PA
Perceptive Advisors
New York
|
+$39.2M |
| 3 |
State Street
Boston,
Massachusetts
|
+$28.8M |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$25.2M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$17.5M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$101M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$15.6M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$6.21M |
| 4 |
Jennison Associates
New York
|
-$5.33M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$5.29M |
